ANA
LLUCH HERNANDEZ
EMÉRITO/A UNIVERSIDAD
Aleix
Prat
Publicaciones en las que colabora con Aleix Prat (12)
2023
2022
-
Targeting HER2-AXL heterodimerization to overcome resistance to HER2 blockade in breast cancer
Science Advances, Vol. 8, Núm. 20
2021
-
Clinical, pathological, and PAM50 gene expression features of HER2-low breast cancer
npj Breast Cancer, Vol. 7, Núm. 1
2020
-
FGFR4 regulates tumor subtype differentiation in luminal breast cancer and metastatic disease
Journal of Clinical Investigation, Vol. 130, Núm. 9, pp. 4871-4887
2019
-
A Pathology-Based Combined Model to Identify PAM50 Non-luminal Intrinsic Disease in Hormone Receptor-Positive HER2-Negative Breast Cancer
Frontiers in Oncology, Vol. 9, Núm. APR
-
Dynamic clonal remodelling in breast cancer metastases is associated with subtype conversion
European Journal of Cancer, Vol. 120, pp. 54-64
2018
-
MSK1 regulates luminal cell differentiation and metastatic dormancy in ER + breast cancer
Nature Cell Biology, Vol. 20, Núm. 2, pp. 211-221
-
Erratum to: MSK1 regulates luminal cell differentiation and metastatic dormancy in ER+ breast cancer (Nature Cell Biology, (2018), 20, 2, (211-221), 10.1038/s41556-017-0021-z)
Nature Cell Biology
2017
-
A PAM50-based chemoendocrine score for hormone receptor-positive breast cancer with an intermediate risk of relapse
Clinical Cancer Research, Vol. 23, Núm. 12, pp. 3035-3044
-
Intrinsic subtypes and gene expression profiles in primary and metastatic breast cancer
Cancer Research, Vol. 77, Núm. 9, pp. 2213-2221
2015
-
Enhanced MAF Oncogene Expression and Breast Cancer Bone Metastasis
Journal of the National Cancer Institute, Vol. 107, Núm. 12
2014
-
Predicting response and survival in chemotherapy-treated triple-negative breast cancer
British Journal of Cancer, Vol. 111, Núm. 8, pp. 1532-1541